Fulgent Genetics (FLGT) Asset Writedowns and Impairment (2016 - 2025)
Fulgent Genetics' Asset Writedowns and Impairment history spans 10 years, with the latest figure at $1.9 million for Q4 2025.
- For Q4 2025, Asset Writedowns and Impairment rose 25.27% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $7.6 million, up 3.41%, while the annual FY2025 figure was $7.6 million, 542.08% up from the prior year.
- Asset Writedowns and Impairment for Q4 2025 was $1.9 million at Fulgent Genetics, up from -$6.2 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $11.6 million in Q1 2022 and bottomed at -$6.2 million in Q3 2025.
- The 5-year median for Asset Writedowns and Impairment is $2.0 million (2025), against an average of $2.8 million.
- The largest annual shift saw Asset Writedowns and Impairment surged 15614.29% in 2021 before it crashed 2109.73% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $4.8 million in 2021, then soared by 52.16% to $7.3 million in 2022, then plummeted by 52.98% to $3.5 million in 2023, then crashed by 57.11% to $1.5 million in 2024, then grew by 25.27% to $1.9 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Asset Writedowns and Impairment are $1.9 million (Q4 2025), -$6.2 million (Q3 2025), and $9.9 million (Q2 2025).